Home >> Report Store >> Healthcare >> Active Pharmaceutical Ingredients Market Size & Industry Report, 2025 >

Active Pharmaceutical Ingredient Market, By Manufacturer (Captive & Merchant), By Synthesis (Synthetic & Biological), Drug Type (Generic, & Branded), By Therapeutic Area, and Geography (North America, Europe, Asia Pacific, And Rest Of The World) – Analysis, Share, Trends, Size, & Forecast From 2014 – 2025

100 Pages | Published Date : 13 / 05 / 17  | Report Code: AV120 | Report Format: PDF

The “Global Active Pharmaceutical Ingredient Market” was estimated to be around US$ 150.0 billion in 2016 and is anticipated to grow with 6.0% of growth rate during the future period.

The report tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analyzing the key micro-markets, the report also focuses on industry-specific drivers, restraints and opportunities in the Active Pharmaceutical Ingredient market. In terms of manufacturer segments of the Active Pharmaceutical Ingredient market Captive API market was the largest segment in 2015, and is expected to lose its share to merchant API market largely due to shift in trend towards CMO’s for API production. Based on synthesis, Synthetic API was the largest segment for Active pharmaceutical ingredient market by synthesis in 2015, but is expected to lose its share to biological API largely due to increasing demand of biosimilars. However, large investment in specialized containment and limited improvement in pharmaceutical facilities may reduce overall growth.

The market size and forecast for each segment has been provided for the period 2014 to 2025, considering 2015 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2016 to 2025 for every reported segment.

The scope of this report covers the Active Pharmaceutical Ingredient market by its major segments, which include the manufacturer, synthesis, drug type, therapeutic area and the major geographic regions. The years considered for the study are:

  • Historical Year – 2014 & 2015
  • Base Year – 2016
  • Estimated Year – 2017
  • Projected Year – 2025

Companies reported in this report are: Pfizer,Inc, Boehringer Ingelheim GmbH, Cambrex Corporation, Novartis AG, Lonza Group, Mylan N.V. and others.

TARGET AUDIENCE

  • Hospitals
  • Manufacturers
  • Traders, Distributors, And Suppliers of API Drugs
  • Government and Regional Agencies and Research Organizations
  • Consultants
  • Distributors

SCOPE OF THE REPORT :

The research report categorizes the Active Pharmaceutical Ingredient Market in each of the following submarkets to forecast the revenues and analyze the trends:

GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET, BY MANUFACTURER

  • Captive
  • Merchant

GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET, BY SYNTHESIS

  • Synthetic
  • Biological

GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET, BY DRUG TYPE

  • Generic
  • Branded

GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET, BY THERAPEUTIC AREA

  • Cardiovascular
  • Metabolic
  • CNS
  • Oncology
  • Musculoskeletal
  • NSAIDS
  • Others

GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET, BY REGION

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET, GEOGRAPHIC ANALYSIS

  • Further Breakdown of The North America Active Pharmaceutical Ingredient Market
    • U.S.
    • Canada
  • Further Breakdown of The Europe Active Pharmaceutical Ingredient Market
    • Germany
    • France
    • Rest of Europe
  • Further Breakdown of The APAC Active Pharmaceutical Ingredient Market
    • India
    • China
    • Rest of APAC
  • Further Breakdown of The Rest of the World Active Pharmaceutical Ingredient Market
    • Middle East and Africa
    • Latin America

TABLE OF CONTENT
1. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET OVERVIEW
1.1. Study Scope
1.2. Assumption and Methodology
2. EXECUTIVE SUMMARY
2.1. Key Market Facts
2.2. Geographical Scenario
2.3. Companies in the Market
3. ACTIVE PHARMACEUTICAL INGREDIENTS KEY MARKET TRENDS
3.1. Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Market Opportunities
3.4. Market Future Trends
4. ACTIVE PHARMACEUTICAL INGREDIENTS INDUSTRY STUDY
4.1. Company Activity Analysis
4.2. Regulatory Framework Analysis
4.3. Value Chain Analysis
5. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET LANDSCAPE
5.1. Market Share Analysis
5.2. Key Innovators
6. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET – BY MANUFACTURER
6.1. Overview
6.2. Captive
6.2.1. Overview
6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
6.3. Merchant
6.3.1. Overview
6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
7. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET – BY SYNTHESIS
7.1. Overview
7.2. Synthetic
7.2.1. Overview
7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
7.3. Biological
7.3.1. Overview
7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET – BY DRUG TYPE
8.1. Overview
8.2. Generic
8.2.1. Overview
8.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.3. Branded
8.3.1. Overview
8.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
9. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET – BY THERAPEUTIC AREA
9.1. Overview
9.2. Cardiovascular
9.2.1. Overview
9.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
9.3. Metabolic
9.3.1. Overview
9.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
9.4. CNS
9.4.1. Overview
9.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
9.5. Oncology
9.5.1. Overview
9.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
9.6. Musculoskeletal
9.6.1. Overview
9.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
9.7. NSAIDS
9.7.1. Overview
9.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
9.8. Others
9.8.1. Overview
9.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
10. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET– BY GEOGRAPHY
10.1. Introduction
10.2. North America
10.2.1. Overview
10.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
10.2.3. U.S.
10.2.3.1. Overview
10.2.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
10.2.4. Canada
10.2.4.1. Overview
10.2.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
10.3.3. France
10.3.3.1. Overview
10.3.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
10.3.4. Germany
10.3.4.1. Overview
10.3.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
10.3.5. Rest of Europe
10.3.5.1. Overview
10.3.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
10.4.3. China
10.4.3.1. Overview
10.4.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
10.4.4. India
10.4.4.1. Overview
10.4.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
10.4.5. Rest of APAC
10.4.5.1. Overview
10.4.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
10.5. Rest of the World
10.5.1. Overview
10.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
10.5.3. Latin America
10.5.3.1. Overview
10.5.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
10.5.4. Middle East and Africa
10.5.4.1. Overview
10.5.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
11. KEY VENDOR ANALYSIS
11.1. Pfizer, Inc.
11.1.1. Company Overview
11.1.2. SWOT Analysis
11.1.3. Key Developments
11.2. Mylan
11.2.1. Company Overview
11.2.2. SWOT Analysis
11.2.3. Key Developments
11.3. Novartis
11.3.1. Company Overview
11.3.2. SWOT Analysis
11.3.3. Key Developments
11.4. Boehringer Ingelheim GmbH
11.4.1. Company Overview
11.4.2. SWOT Analysis
11.4.3. Key Developments
11.5. Lonza
11.5.1. Company Overview
11.5.2. SWOT Analysis
11.5.3. Key Developments
11.6. Aurobindo
11.6.1. Company Overview
11.6.2. SWOT Analysis
11.6.3. Key Developments
*Client can request additional company profiling as per specific requirements
12. 360 DEGREE ANALYSTVIEW
13. APPENDIX
13.1. Research Methodology
13.2. Abbreviations
13.3. Disclaimer
13.4. Contact Us

List of Tables
Table 1 List of Acronyms
Table 2 Key Market Facts, 2014 – 2025
Table 3 Market Drivers: Impact Analysis
Table 4 Market Restraint: Impact Analysis
Table 5 Market Opportunity: Impact Analysis
Table 6 PEST Analysis
Table 7 Porter’s Five Forces Analysis
Table 8 Company Market Share Analysis
Table 9 Global Active Pharmaceutical Ingredients Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
Table 10 Active Pharmaceutical Ingredients Market, by Manufacturer, 2014 – 2025 (USD Million)
Table 11 Active Pharmaceutical Ingredients Market, by Synthesis, 2014 – 2025 (USD Million)
Table 12 Active Pharmaceutical Ingredients Market, by Drug Type, 2014 – 2025 (USD Million)
Table 13 Active Pharmaceutical Ingredients Market, by Therapeutic Area, 2014 – 2025 (USD Million)
Table 14 Active Pharmaceutical Ingredients Market, by Geography, 2014 – 2025 (USD Million)
Table 15 North America Active Pharmaceutical Ingredients Market, 2014 – 2025 (USD Million)
Table 16 U.S. Active Pharmaceutical Ingredients Market, 2014 – 2025 (USD Million)
Table 17 Canada Active Pharmaceutical Ingredients Market, 2014 – 2025 (USD Million)
Table 18 Europe Active Pharmaceutical Ingredients Market, 2014 – 2025 (USD Million)
Table 19 France Active Pharmaceutical Ingredients Market, 2014 – 2025 (USD Million)
Table 20 Germany Active Pharmaceutical Ingredients Market, 2014 – 2025 (USD Million)
Table 21 Asia Pacific Active Pharmaceutical Ingredients Market, 2014 – 2025 (USD Million)
Table 22 China Active Pharmaceutical Ingredients Market, 2014 – 2025 (USD Million)
Table 23 India Active Pharmaceutical Ingredients Market, 2014 – 2025 (USD Million)
Table 24 Latin America Active Pharmaceutical Ingredients Market, 2014 – 2025 (USD Million)
Table 25 MEA Active Pharmaceutical Ingredients Market, 2014 – 2025 (USD Million)

List of Figures
Figure 1 Research Methodology
Figure 2 Research Process Flow Chart
Figure 3 Comparative Analysis, by Geography, 2016-2025 (Value %)
Figure 4 Regulatory Framework Analysis
Figure 5 Supply Chain Analysis Analysis
Figure 6 Active Pharmaceutical Ingredients Market, by Manufacturer, 2014 – 2025 (USD Million)
Figure 7 Active Pharmaceutical Ingredients Market, by Synthesis, 2014 – 2025 (USD Million)
Figure 8 Active Pharmaceutical Ingredients Market, by Drug Type, 2014 – 2025 (USD Million)
Figure 9 Active Pharmaceutical Ingredients Market, by Therapeutic Area, 2014 – 2025 (USD Million)
Figure 10 Active Pharmaceutical Ingredients Market, by Geography, 2014 – 2025 (USD Million)

SCOPE AND OBJECTIVES
The objective of this report is to describe the market trends and revenue forecasts for the market for the upcoming years. The report focuses on defining and describing the key influencing factors for the growth of the market. It also offers an in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key market players, and premium industry trends.
The report tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analysing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities and challenges in the market. The scope of this report covers the market by its major segments.

KEY BENEFITS OF THE REPORT
• In-depth analysis of the key market dynamics
• Granular analysis of the current market scenario and expected factors to affect the market
• Detailed analysis of the geographic region, regional and county wise analysis
• Highlight on the strategies that are being adopted by the key players in this market to stay competitive
• Extensive analysis of the key players dominating the market

AnalystView’s research methodology is developed on a combination of specialist industry analyst knowledge and in-country research experience. We employ data interrogation methodologies to generate new and meaningful analyses and insights. The research study involves extensive usage of secondary sources, directories, and databases (such as Hoovers, Bloomberg, and Businessweek) to identify and collect information useful to understand technical, market-oriented, and commercial aspects of market. Market data and information are also collected and not limited to secondary sources like:

 

  • Official Company’s Website, Financial and Annual Reporting
  • Government Statistical Data
  • Online Publishing Articles
  • Industry Player’s Investor Presentations
  • Economic News Articles
  • National and International Trade Associations
  • The Financial, Business and Mainstream Press
  • Industry Study Groups and Other Semi-Official Sources
  • Many Other Informative Channels Related to the Market Topics
  • Gathering data through secondary sources is only the first step. The ability to cross-refer market data through available secondary information often conflicting across multiple sources is a key aspect of the added value we provide

In order to verify and validate secondary market data, we engage with a variety of personnel in key players at all points through phone calls, emails and web based survey responses with key opinion leaders (KoL’s) operating in the respective markets. The engagement involves the CEO, vice presidents, top-level and middle-level managers of the company, directors of marketing, product managers, brand managers, customers of major industrial products, and many others. We also interview manufacturers, distributors, materials suppliers, retailers, service operators, study groups, industry associations, and third party observers from the trade and financial press. These obtained information helped us to understand several facets of the market with respect to manufacturers’ and buyers’ perspective. These data were carefully filtered, analyzed, compared and presented in an easy way to develop accurate research study. Furthermore, all collected data is subjected to undergo exhaustive review process at country level, regional level and global level.

MARKET FORECAST

Market forecast for the respective market is primarily based on the year on year (YOY) growth rate. Data projection and future performance of each segment analyzed based on the key aspects extracted from primary and secondary research results. Thus data projection states the assumption on how the market behaves under macroeconomic and microeconomic parameters. Our market forecasting represents strategic conclusion we have reached about the coming state of the market scenario.

MARKET ANALYSIS

Another integral part of our research study is that AnalystView’s market data is accompanied by clear written analysis. We include detail information on market segments in terms of market drivers, market restraints and market opportunities. These offer insights of different channel dynamics, brand preference, incidence/prevalence data, technology up gradation, consumption trend, and future market scenario. We also include supporting data with any relevant awareness campaign, new introduction, regulatory norms, government initiatives, and industry player’s expansion in specific product segments. From research perspective, this information explains and substantiates estimated data finding and forecast.

Why AnalystView?

 

Z

Trusted Partnership

We strive to become one of the trusted partner of our client by offering value added services and concrete research data.

Y

Tailor Made Solutions

From single reports and data downloads to enterprise subscriptions to custom consultancy, we can base our precise solutions round our client’s exact needs.

Turnaround Time

Our analyst aims to provide research studies in quickest turnaround time and in a much cost effective manner.

T

Data Accuracy And Reliablity

We utilize a mix of primary, secondary research, and machine learning algorithms to generate accurate and comprehensive data about market size and revenue forecasts.

Competitive Pricing

We offer most competitive pricing policy across the research industry

Client Testimonials

 

Asia Pacific based Chemical Industry (Privacy Requested)

Thanks AnalystView for putting a great team to work on our research projects. It was a smooth transition of knowledge and delivery was seamless. We are keen to work with you on our upcoming projects. Thank you once again for the professional attitude your team has demonstrated.

CEO, Europe based Digital Media Company (Privacy Requested)

We had confusion after receiving the final data sheet of report. As per some preliminary we already have, we believe the market is over estimated.. However, after string of calls with analyst, we found their final research analysis was methodologically sound and their work to be very professional and up […]

Managing Director, Chemical based Company, Asia Pacific (Privacy Requested)

We are happy with the way the AnalystView member understood the brief and went about executing our research project.

U.S. Headquartered Medical Device Company (Privacy Requested)

AnalystView team has done brand assessment study for blood glucose monitoring devices market, in which we want enter into….We were very impressed not only by their research skills but also by their understanding of issues relevant to our requirements…!!

Vice President, Petrochemical Firm based in China (Privacy Requested)

It was a pleasure assigning project to AnalystView; they are reliable, fast and friendly. Highly recommend this company for research workJGood stuff!

US based healthcare service provider (Privacy Requested)

Frankly, we didn’t expect much comprehensive data for the report we purchased. To be surprised, I must say the report we received was very nicely executed….It contains all the information we are looking for and satisfied with the quality of the report. Thank you team

Europe based Chemical Industry (Privacy Requested)

Just wanted to say massive thanks for all the help from the AnalystView team. We purchased two reports one is Food Safety Testing report and another one is Enzyme market. These reports have helped us build a sound knowledge base of our business segments and have taken our business to […]

Why Choose Us

 

We devise research report with quality data:

Combined with an in-depth knowledge of the current industry and a sharp analytical mind, AnalystView serve our customer accurate research in accordance with a constantly evolving industry.

We work with businesses just like yours: 

AnalystView committed to making a positive difference for our clients. This means whatever you demand, chances are we already have experience with something similar.

 

Share This